ATC Level5: M01AH06 - Lumiracoxib
- M01 - Antiinflammatory and antirheumatic products
- M01A - Antiinflammatory and antirheumatic products, non
Drugs in ATC category "M01AH06":
- Lumiracoxib - Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug. On August 11, 2007, Australia’s Therapeutic Goods Administration (TGA, the Australian equivalent of the FDA) cancelled the registration of lumiracoxib in Australia due to concerns that it may cause liver failure. New Zealand and Canada have also followed suit in recalling the drug. Indication: For the acute and chronic treatment of the signs and symptoms of osteoarthritis of the knee in adults. Lumiracoxib...
The information was verified by Dr. Rachana Salvi, MD Pharmacology
© 2002 - 2022 "sdrugs.com". All Rights Reserved